Difference between revisions of "Pitt JM, et al. J. Clin. Invest. (2016) cited as Ref 546 in DOI: 10.1038/s41392-020-0110-5 (Q9809)"
Jump to navigation
Jump to search
(Created claim: title (P93): Dendritic cell-derived exosomes for cancer therapy, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 1224-, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 1224- | ||
| Property / Page(s): 1224- / rank | |||
| + | Normal rank | ||
Latest revision as of 15:44, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pitt JM, et al. J. Clin. Invest. (2016) cited as Ref 546 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pitt JM
0 references
2016
0 references
J. Clin. Invest.
0 references
126
0 references
Dendritic cell-derived exosomes for cancer therapy (English)
0 references
1224-
0 references
